In Silico Study: Combination of α-Mangostin and Chitosan Conjugated with Trastuzumab against Human Epidermal Growth Factor Receptor 2

Breast cancer is a type of cancer with the highest prevalence worldwide. Almost 10–30% of breast cancer cases are diagnosed as positive for HER2 (human epidermal growth factor receptor 2). The currently available treatment methods still exhibit many shortcomings such as a high incidence of side effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Megantara, Sandra, Wathoni, Nasrul, Mohammed, Ahmed Fouad Abdelwahab, Suhandi, Cecep, Ishmatullah, Maryam H., Putri, Melisa F. F. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268814/
https://www.ncbi.nlm.nih.gov/pubmed/35808792
http://dx.doi.org/10.3390/polym14132747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268814/
https://www.ncbi.nlm.nih.gov/pubmed/35808792
http://dx.doi.org/10.3390/polym14132747

Ejemplares similares